WELL-DIFFERENTIATED THYMIC CARCINOMA - AN ORGANOTYPICAL LOW-GRADE CARCINOMA WITH RELATIONSHIP TO CORTICAL THYMOMA

被引:139
作者
KIRCHNER, T
SCHALKE, B
BUCHWALD, J
RITTER, M
MARX, A
MULLERHERMELINK, HK
机构
[1] UNIV WURZBURG,DEPT NEUROL,W-8700 WURZBURG,GERMANY
[2] UNIV WURZBURG,DEPT CARDIAC & THORAC SURG,W-8700 WURZBURG,GERMANY
[3] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT IMMUNOL,LONDON W12 0HS,ENGLAND
关键词
THYMIC CARCINOMA; THYMOMA; THYMUS; MYASTHENIA GRAVIS;
D O I
10.1097/00000478-199212000-00003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Based on a study of 26 cases, the well-differentiated thymic carcinoma is described as a distinct organotypical carcinoma of the thymus with low-grade malignancy. It is characterized by a predominance of epithelial cells with usually low mitotic rate, an epidermoid differentiation with slight to moderate cytological atypia, the constant presence of interepithelial immature cortical thymocytes, lobular growth, and formation of epithelial palisades around perivascular spaces. The tumor occurs at age 14 to 76 years in both sexes. An association with myasthenia gravis is found in 77% of the patients, and 83% of the tumors show invasion of adjacent organs or endothoracic metastasis at primary operation. This rate is higher than in cortical thymomas (47%) but lower than in other thymic carcinomas (92%). Two of 18 patients with follow-up died of tumor recurrence and pleural metastasis. Well-differentiated thymic carcinoma can be related to cortical thymoma by common morphological features and a similar immunophenotype of epithelial cells. It must be differentiated from the lymphocyte-depleted cortical thymomas after corticosteroid treatment and from the benign epithelial-rich medullary thymomas.
引用
收藏
页码:1153 / 1169
页数:17
相关论文
共 54 条
[41]   IDENTIFICATION OF HODGKIN AND STERNBERG-REED CELLS AS A UNIQUE CELL TYPE DERIVED FROM A NEWLY-DETECTED SMALL-CELL POPULATION [J].
STEIN, H ;
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
MASON, DY ;
ZIEGLER, A ;
SCHIENLE, W ;
DIEHL, V .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) :445-459
[42]   UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY - PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES [J].
STERNBER.LA ;
HARDY, PH ;
CUCULIS, JJ ;
MEYER, HG .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1970, 18 (05) :315-&
[43]  
SUSTER S, 1991, CANCER, V67, P1025
[44]   THE HISTOLOGY OF TUMOURS OF THE THYMUS [J].
THOMSON, AD ;
THACKRAY, AC .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :348-&
[45]   THYMIC CARCINOMA - A CLINICOPATHOLOGICAL STUDY OF 13 CASES [J].
TRUONG, LD ;
MODY, DR ;
CAGLE, PT ;
JACKSONYORK, GL ;
SCHWARTZ, MR ;
WHEELER, TM .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (02) :151-166
[46]   CHARACTERISTICS OF MONOCLONAL-ANTIBODIES TO DENATURED TORPEDO AND TO NATIVE CALF ACETYLCHOLINE-RECEPTORS - SPECIES, SUBUNIT AND REGION SPECIFICITY [J].
TZARTOS, S ;
LANGEBERG, L ;
HOCHSCHWENDER, S ;
SWANSON, LW ;
LINDSTROM, J .
JOURNAL OF NEUROIMMUNOLOGY, 1986, 10 (03) :235-253
[47]  
TZARTOS SJ, IN PRESS EUR J BIOCH
[48]   AN IMMUNOHISTOLOGIC STUDY OF THE EPITHELIAL AND LYMPHOID COMPONENTS OF 6 THYMOMAS [J].
VANDERKWAST, TH ;
VANVLIET, E ;
CRISTEN, E ;
VANEWIJK, W ;
VANDERHEUL, RO .
HUMAN PATHOLOGY, 1985, 16 (10) :1001-1008
[49]  
VERLEY JM, 1985, CANCER, V55, P1074, DOI 10.1002/1097-0142(19850301)55:5<1074::AID-CNCR2820550524>3.0.CO
[50]  
2-T